A detailed history of Jaffetilchin Investment Partners, LLC transactions in Incyte Corp stock. As of the latest transaction made, Jaffetilchin Investment Partners, LLC holds 59 shares of INCY stock, worth $4,476. This represents 0.0% of its overall portfolio holdings.

Number of Shares
59
Holding current value
$4,476
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$57.33 - $68.61 $3,382 - $4,047
59 New
59 $3,000
Q3 2019

Oct 15, 2019

SELL
$72.82 - $86.52 $228,581 - $271,586
-3,139 Closed
0 $0
Q2 2019

Aug 13, 2019

SELL
$73.52 - $88.7 $36,392 - $43,906
-495 Reduced 13.62%
3,139 $267,000
Q1 2019

May 13, 2019

BUY
$63.56 - $88.17 $230,977 - $320,409
3,634 New
3,634 $313,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.9B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Jaffetilchin Investment Partners, LLC Portfolio

Follow Jaffetilchin Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jaffetilchin Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jaffetilchin Investment Partners, LLC with notifications on news.